Connors Investor Services’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-8,424
Closed -$341K 161
2025
Q3
$341K Sell
8,424
-1,722
-17% -$56.9K 0.03% 112
2025
Q2
$259K Sell
10,146
-100
-1% -$2.18K 0.02% 126
2025
Q1
$219K Sell
10,246
-2,200
-18% -$49.2K 0.02% 134
2024
Q4
$261K Sell
12,446
-200
-2% -$4.63K 0.02% 126
2024
Q3
$285K Sell
12,646
-4,000
-24% -$77.2K 0.03% 125
2024
Q2
$279K Hold
16,646
0.03% 122
2024
Q1
$215K Hold
16,646
0.02% 144
2023
Q4
$193K Buy
16,646
+2,500
+18% +$28.2K 0.02% 144
2023
Q3
$181K Sell
14,146
-955
-6% -$13.5K 0.02% 141
2023
Q2
$207K Buy
15,101
+2,000
+15% +$28.7K 0.02% 147
2023
Q1
$201K Hold
13,101
0.02% 149
2022
Q4
$176K Buy
13,101
+3,100
+31% +$41.6K 0.02% 150
2022
Q3
$133K Hold
10,001
0.02% 147
2022
Q2
$191K Buy
+10,001
New +$189K 0.02% 142

Other funds holding PAHC

Connors Investor Services's PAHC Position: Q4 2025 in Review

Connors Investor Services sold out of Phibro Animal Health (PAHC) in Q4 2025, closing a stake of 8,424 shares — an estimated $341K sold.

Connors Investor Services first reported a position in PAHC in Q2 2022 and held it in 14 quarters. The position peaked at $341K in Q3 2025. 227 funds tracked by Wall St. Rank hold PAHC as of Q4 2025.

  • Connors Investor Services reported no remaining Phibro Animal Health position as of Q4 2025 after selling out during the quarter.
  • Connors Investor Services sold 8,424 Phibro Animal Health shares in Q4 2025, an estimated $341K.
  • Connors Investor Services first reported a position in Phibro Animal Health in Q2 2022 and held it in 14 quarters.
  • Connors Investor Services's Phibro Animal Health position peaked at $341K in Q3 2025.
  • 227 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2025.

Based on Connors Investor Services's 13F filing for Q4 2025, filed 9 Feb 2026.